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Abstract
Following a request from the European Commission, EFSA was asked to deliver a scientiﬁc opinion on
the safety and efﬁcacy of Taminizer D (dimethylglycine sodium salt) as a feed additive for chickens for
fattening, based on a dossier submitted for the modiﬁcation of the terms of authorisation of the
additive. The product is authorised in the European Union for chickens for fattening at the maximum
content of 1,000 mg/kg complete feedingstuffs. The applicant proposed the introduction of an
additional manufacturing process, which introduces an impurity (dimethylamino-ethanol (DMAE)) in the
additive at concentrations up to 0.09%. The EFSA Panel on Additives and Products or Substances used
in Animal Feed (FEEDAP) considered that the proposed modiﬁcation would not substantially affect the
previous assessment as related to the safety of the environment and the efﬁcacy of the product. Since
the safety of the active substance was established, the current assessment has dealt with the impurity
DMAE. Considering the toxicological proﬁle of DMAE, the estimated intake by the target animal and
consumers, and making use of the Threshold of Toxicological Concern (TTC) approach, the
Panel concluded that Taminizer D, manufactured by the DMAE route, is safe for both chickens for
fattening and consumers, up to the maximum level of 1,000 mg/kg feed. The FEEDAP Panel extends
its conclusions about Taminizer D produced by the original method to cover also Taminizer D produced
by the new DMAE method. There is minimal risk to users from dust produced as a result of normal
handling of the additive. Taminizer D is not irritant to skin but may be irritant to eyes; it is regarded as
a potential skin sensitiser. The FEEDAP Panel recommended to set a speciﬁcation for the DMAE content
in the additive.
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1. Introduction
1.1. Background and Terms of Reference
Regulation (EC) No 1831/20031 establishes the rules governing the Community authorisation of
additives for use in animal nutrition. In particular, Article 13(3) of that Regulation lays down that if the
holder of an authorisation proposes changing the terms of the authorisation by submitting an
application to the Commission, accompanied by the relevant data supporting the request for the
change, the Authority shall transmit its opinion on the proposal to the Commission and the Member
States.
The European Commission received a request from Taminco B.V.B.A (a subsidiary of Eastman
Chemical Company)2 for authorisation of the product Taminizer D (dimethylglycine sodium salt), when
used as a feed additive for chickens for fattening (category: zootechnical additive; functional group:
other zootechnical additives).
According to Article 7(1) of Regulation (EC) No 1831/2003, the Commission forwarded the
application to the European Food Safety Authority (EFSA) as an application under Article 13(3)
(modiﬁcation of the authorisation of a feed additive). EFSA received directly from the applicant the
technical dossier in support of this application. The particulars and documents in support of the
application were considered valid by EFSA as of 28 February 2017.
According to Article 8 of Regulation (EC) No 1831/2003, EFSA, after verifying the particulars and
documents submitted by the applicant, shall undertake an assessment in order to determine whether
the feed additive complies with the conditions laid down in Article 5. EFSA shall deliver an opinion on
the safety for the target animals, consumer, user and the environment and on the efﬁcacy of the
product Taminizer D (dimethylglycine sodium salt), when used under the proposed conditions of use
(see Section 3.1.3).
1.2. Additional information
The additive Taminizer D is a preparation of dimethylglycine sodium salt (DMG-Na) produced by
chemical synthesis. The additive is intended to increase the performance of chickens for fattening. The
safety and efﬁcacy of the additive when used in chickens for fattening was the subject of an opinion
published in 2011 (EFSA FEEDAP Panel, 2011a).
The product is authorised in the European Union (EU) for its use in chickens for fattening3 at the
maximum content of 1,000 mg/kg complete feedingstuffs.
2. Data and methodologies
2.1. Data
The present assessment is based on data submitted by the applicant in the form of a technical
dossier4 in support of the authorisation request for the use of Taminizer D (dimethylglycine sodium
salt) as a feed additive. The technical dossier was prepared following the provisions of Article 7 of
Regulation (EC) No 1831/2003, Regulation (EC) No 429/20085 and the applicable EFSA guidance
documents.
The FEEDAP Panel used the data provided by the applicant together with data from other sources,
such as previous risk assessments by EFSA or other expert bodies.
The European Union Reference Laboratory (EURL) considered that the conclusions and
recommendations reached in the previous assessment are valid and applicable for the current
application.6
1 Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in
animal nutrition. OJ L 268, 18.10.2003, p. 29.
2 Taminco N.V. (a subsidiary of Eastman Chemical Company), Pantserschipstraat 207, B-9000 Gent, Belgium.
3 Regulation (EU) No 371/2011 of 15 April 2011 concerning the authorisation of dimethylglycine sodium salt as feed additive for
chickens for fattening. OJ L 102, 16.4.2011, p. 6.
4 FEED dossier reference: FAD-2016-0072.
5 Commission Regulation (EC) No 429/2008 of 25 April 2008 on detailed rules for the implementation of Regulation (EC)
No 1831/2003 of the European Parliament and of the Council as regards the preparation and the presentation of applications
and the assessment and the authorisation of feed additives. OJ L 133, 22.5.2008, p. 1.
6 The full report is available on the EURL website: https://ec.europa.eu/jrc/sites/jrcsh/files/FinRep-FAD-2009-0036.pdf
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2.2. Methodologies
The approach followed by the FEEDAP Panel to assess the safety and the efﬁcacy of Taminizer D
(dimethylglycine sodium salt) is in line with the principles laid down in Regulation (EC) No 429/2008
and the relevant guidance documents: Guidance on zootechnical additives (EFSA FEEDAP Panel,
2012a), Technical guidance: Tolerance and efﬁcacy studies in target animals (EFSA FEEDAP Panel,
2011b), Technical Guidance for assessing the safety of feed additives for the environment (EFSA,
2008), Guidance for establishing the safety of additives for the consumer (EFSA FEEDAP Panel, 2012b)
and Guidance on studies concerning the safety of use of the additive for users/workers (EFSA FEEDAP
Panel, 2012c).
3. Assessment
The additive Taminizer D is a preparation of DMG-Na produced by chemical synthesis. The product
is authorised as a zootechnical additive, under the functional group of other zootechnical additives,
intended to increase the performance of chickens for fattening at the recommended dose of
1,000 mg/kg complete feedingstuffs.
The application is for the modiﬁcation of the current authorisation to introduce an additional
manufacturing process.
3.1. Characterisation
3.1.1. Manufacturing process
The manufacturing process is described in the dossier.7
•
•
•
3.1.2. Characterisation of the additive
The additive is a ‘white microgranular’ product containing at least 97% of DMG-Na and not more
than 3% of impurities, including water.
The analysis of ﬁve batches of Taminizer D obtained with the alternative manufacturing process
showed a mean content of DMG-Na of 97.5% (range 97.1–97.9%).8 Residual DMAE was also analysed
in the ﬁve batches of the additive.9 The results for DMAE were in the range of < 0.07%10 to 0.09%.
The content of undesirable substances, including heavy metals, arsenic, nitrites and dioxins, were
analysed in three batches of the additive.11,12,13,14 The highest results reported were: arsenic
< 0.25 mg/kg, cadmium < 0.13 mg/kg, lead < 0.15 mg/kg, mercury < 0.1 mg/kg, ﬂuorine 0.06 mg/kg,
nitrites < 5, dioxins 0.048 ng WHO-PCDD/F-TEQ per kg and sum of dioxins plus dioxin-like PCBs
0.10 ng WHO-PCDD/F-PCBTEQ per kg.15
7 Technical dossier/Section II/Identity.
8 Technical dossier/Section II/4.Annex II_2.
9 Technical dossier/Section II/5.Annex II_2.
10 Corresponding to the Limit of Quantiﬁcation of the analytical method: 0.07%. Technical dossier/Section II/Annex II_9.
11 Technical dossier/Section II/6.Annex II_3.
12 Technical dossier/Section II/7.Annex II_4.
13 Technical dossier/Supplementary Information/October 17/Annex 7, 8a, 8b, 8c, 9a, 9b, 9c.
14 Technical dossier/Supplementary Information/January 18.
15 Values preceded with the sign ‘<’ indicates that correspond to the limit of quantiﬁcation (LOQ). The analysis was done by two
different laboratories reporting different LOQs for each analyte.
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Particle size distribution was assessed by sieve screening: particles below 100 lm, 53 lm and
45 lm were reported, being less than 0.1% in the two latter cases.16
The dusting potential was analysed in two samples of the additive, following a procedure
compatible with the Collaborative International Pesticides Analytical Council (CIPAC) method MT171.17
The highest value obtained was 0.2 mg/30 g16; according to the categories proposed by the CIPAC,
this value corresponds to a ‘nearly dust free’ product.
3.1.3. Stability and homogeneity
Based on the physicochemical properties, there are no relevant differences regarding the feed
additive produced by either manufacturing routes. Therefore, in the view of the FEEDAP Panel the
data reported in the ﬁrst dossier and evaluated by the Panel (EFSA FEEDAP Panel, 2011a) regarding
stability and homogeneity are still valid.
3.1.4. Conditions of use
The additive is intended to be used to increase the performance of chickens for fattening at the
maximum dose of 1,000 mg/kg complete feedingstuffs.
3.2. Safety
The FEEDAP Panel assessed the safety and efﬁcacy of Taminizer D in a previous opinion (EFSA
FEEDAP Panel, 2011a). From the safety standpoint, the principal change, as compared to the previous
opinion, is the presence of DMAE as an impurity previously not assessed and the potential toxicological
signiﬁcance of the amount of DMAE present. Accordingly, the current assessment by the FEEDAP
Panel pivots on whether the presence of DMAE in the additive can be considered safe for the target
species, the consumer, the user and the environment.
3.2.1. Toxicological proﬁle of DMAE
A literature search concerning the toxicological proﬁle of DMAE has been provided18 and is
summarised below.19
• DMAE did not show genotoxicity in an appropriate set of tests (two bacterial reverse mutation
assays, one hypoxanthine-guanine-phosphoribosyltransferase (HGPRT) forward mutagenicity
assay in vitro on CHO cells, one in vitro sister chromatid exchange assay on CHO cells, one
unscheduled DNA synthesis assay performed in vitro on rat hepatocytes, two in vivo
micronucleus assays on mice by the intraperitoneal route using dose levels up to 860 mg/kg bw).
• Subchronic oral toxicity assays were not available. One inhalation subchronic study on rats showed
no effects indicating toxicity other that adverse changes in the upper respiratory tract and corneal
opacity. Thus, the results of this study indicate site-of-contact toxicity with a no-observed adverse-
effect concentration (NOAEC) of 87.5 mg/m³. There was no indication of any systemic toxicity.
• A carcinogenicity assay was performed with single low dose levels of DMAE administered for at
least 2 years via drinking water to female mice belonging to two strains prone to the
development of mammary tumours; 0.9 mg/L or 1.3 mg/L to C3H/HeN and C3H/He J+ mice,
respectively, corresponding to 0.08 or 0.12 mg/kg bw per day. No treatment-related effects
were observed.
• No multigeneration or one-generation reproduction toxicity studies are available. No effects on
reproductive tissues were observed in the subchronic inhalation toxicity study in rats or in the
carcinogenicity assay in female mice.
• In mouse embryos in vitro, 375 lM DMAE caused death and morphological abnormalities
related to the inhibition of choline uptake and metabolism. DMAE was given orally to rat dams
from gestation day 6 until post-natal day 3 at the dose levels of 300 and 600 mg/kg bw per
day. The results showed maternal toxicity (stomach erosion/ulceration, with increased liver
weight at the top dose level) and pre/perinatal toxicity (increased post-implantation loss and
reduced viability of newborn pups) at both doses levels. No oral no-observed-adverse-effect
16 Technical dossier/Supplementary Information/October 17/Annex 10.
17 CIPAC MT 171.1 Dustiness of Granular Products.
18 Technical dossier/Supplementary Information/October 17/Annex 11.
19 Technical dossier/Supplementary Information/October 17/Annex 12, Annex 13.
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level (NOAEL) can be derived for either maternal or developmental toxicity. No adverse effects
were observed in litters from pregnant rat dams exposed by inhalation to up to 365 mg/m3 on
pregnancy days 6–15; conversely, the treatment induced maternal toxicity (reduced weight
gain, ocular changes) with a NOAEC of 36.5 mg/m3. Overall, DMAE showed developmental
toxicity in vivo at dose levels causing maternal toxicity.
The FEEDAP Panel additionally considered a review of the available toxicological literature of DMAE
published in the US National Institute of Environmental Health Sciences (NIEHS, 2002). According to
the US NIEHS review, most of the DMAE given orally enters the metabolic route for the synthesis of
phospholipids; up to 33% is excreted unchanged in humans. The document also conﬁrms the
information on DMAE toxicology provided in the literature review submitted, including the evidence for
the absence of genotoxicity potential.
In addition, the US NIEHS review reports that DMAE tartrate may induce pharmacological effects in
humans (increase in muscle tone and perhaps an increased frequency of convulsions in susceptible
individuals) at dose levels equal to or greater than 20 mg/day (0.3 mg/kg bw per day in a 60-kg
individual). A pharmacological no-observed-effect level (NOEL) is not identiﬁed; the FEEDAP
Panel notes that a possible relationship between pharmacological effects with an inhibitory effect on
choline may not be ruled out.
Overall, DMAE can elicit serious adverse effects on respiratory tract and eyes upon inhalation
exposure and can cause damage to the stomach when given orally. These effects were probably due
to the corrosive nature of DMAE. The increased liver weight seen only in pregnant rats in the top dose
group (600 mg DMAE/kg bw per day) of the developmental toxicity study was not conﬁrmed by a
ﬁnding of liver pathology. The available data do not indicate concerns for mutagenicity/genotoxicity,
carcinogenicity or organ toxicity resulting from the presence of the contaminant DMAE in Taminizer D.
Pre/perinatal toxicity was seen in an oral rat developmental toxicity study in the presence of maternal
toxicity. DMAE may induce pharmacological effects in humans and by implication possibly also in
animals. Since oral toxicity was not fully investigated (there were no available oral subchronic toxicity
studies or multigeneration/extended one-generation reproduction studies; the carcinogenicity/chronic
toxicity study was inadequate as it used only single dosages given to each strain of mouse), an oral
NOAEL for DMAE toxicity cannot be reliably derived.
3.2.2. Safety for chickens for fattening
The previous opinion (EFSA FEEDAP Panel, 2011a) showed that a 10-fold overdose of DMG-Na was
well tolerated by chickens for fattening during the 39-day tolerance study.
The alternative manufacturing process changing the synthesis route of the DMG-Na and starting
from different raw materials introduced residual DMAE in the ﬁnal product. A tolerance trial was
performed to study the effect of an overdosing of residual DMAE on the safety of chickens for
fattening and the possible deposition of DMAE in the edible parts.20
A total of 30 one-day-old male Ross 308 chickens were allotted to two treatments, each with one
pen of 15 birds. The animals were fed a basal maize-soybean meal diet supplemented with Taminizer
D at either 0 or 1,000 mg/kg. Supplementary DMAE was added to the Taminizer D and therefore the
concentration of DMAE in the batch of the additive used was 0.79% (7.9 mg/kg feed), which
corresponded to a 89 overdosing compared to the highest DMAE concentration of 0.09% measured
in the additive.21 Birds were fed a starter diet from day 1 until day 14, a grower diet from day 15 until
day 28 and a ﬁnisher diet from day 29 until day 43. Feed was provided ad libitum. The conﬁrmed
Taminizer D concentration was 1,164 mg/kg in the starter diet, 980 mg/kg in the grower diet and
733 mg/kg in the ﬁnisher diet22; therefore, the corresponding actual DMAE concentrations were 9.2,
7.7 and 5.8 mg/kg feed, respectively.
Animals were monitored for health status and mortality. At the end of the trial (day 43), all
chickens were killed and blood was taken for measurement of haematological23 and serum
biochemistry parameters.24 From all chickens, samples of liver, kidney, abdominal fat and breast meat
20 Technical dossier/Section III/2.Annex III_1.
21 Technical dossier/Section III/3.Annex III_2.
22 Technical dossier/Section III/3.Annex III_4.
23 Haemoglobin, erythrocytes, total leucocytes, heterophils, lymphocytes, monocytes, basophils, eosinophils.
24 Uric acid, total protein, albumin, cholesterol, triglycerides, alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT),
aspartate aminotransferase (AST).
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were taken to determine the deposition of DMAE. No report on gross pathology was provided and no
histopathology was performed.
No treatment-related clinical signs were observed and no deaths were recorded. Haematological
and biochemical parameters were similar in the unsupplemented and the treated groups, although no
statistical analysis was performed. Content of DMAE (89 dose) was below the limit of detection (LOD)
(8.3 mg/kg dry matter (DM)) in muscle and fat. For liver and kidney, DMAE content was 19 and 17.5
mg/kg (DM), respectively (corresponding to 5.4 and 4.2 mg/kg fresh tissue); seven samples of liver
tissue and two samples of kidney tissue, out of 15 in each case, were above the limit of quantiﬁcation
of the method (15.1 mg/kg DM) and were used for calculations.25
The FEEDAP Panel considers that the study presents several limitations (e.g. no experimental
replicates, no tolerance doses of the additive, no statistical analysis was performed); therefore, the
study can only provide information for potential tissue deposition of DMAE.
The FEEDAP Panel applied the Threshold of Toxicological Concern (TTC) approach (EFSA and WHO,
2016) to DMAE. The compound DMAE belongs to Cramer structural Class I. According to this
classiﬁcation, the maximum acceptable concentration of DMAE in poultry feed is 1 mg/kg feed (EFSA
FEEDAP Panel, 2012d); this amount is above the maximum measured concentration of DMAE in feeds
(0.9 mg/kg feed).
3.2.2.1. Conclusions on safety for the target species
Since the safety of the active substance, DMG-Na, has been established, the current assessment
has dealt with the issue of tolerance of the impurity DMAE, which is present in the additive at
concentrations up to 0.09%. Taking into account the toxicological proﬁle of DMAE, the estimated
intake by the target animal and making use of the TTC approach, the FEEDAP Panel concludes that the
presence of this impurity in Taminizer D up to the highest level detected in the additive is unlikely to
cause adverse effects in chickens for fattening. Therefore, Taminizer D, manufactured by the DMAE
route and containing ≤ 0.1% DMAE, is safe for chickens for fattening up to the maximum level of
1,000 mg/kg feed.
3.2.3. Safety for the consumer
The safety of the active substance was already established. The FEEDAP Panel is not aware of any
new information that could modify the previous assessment of the active substance; in addition,
conditions of use of the additive are the same, thus the consumer exposure to the active substance
remains unchanged.
However DMAE is an impurity whose relevance to consumer safety has not been evaluated by
EFSA. The FEEDAP Panel notes that with regard to oral exposure, DMAE is found in ﬁsh (e.g. salmon
roe) and in pig and human brain; Honegger and Honegger (1959) reported a total DMAE (bound to
phospholipids and unbound) of 1,922 lg/kg salmon roe, and of 247 lg/kg pig brain. DMAE appears to
be used in the USA as an ingredient of commercial food dietary supplements.26 In the EU, DMAE is not
included in Annex II (Vitamin and mineral substances which may be used in the manufacture of food
supplements) of the Directive 2002/46/EC. In general, the available data are too limited to allow any
conclusion on consumer exposure from other potential dietary sources of DMAE.
In the tolerance study in chickens (see Section 3.2.2), a concentration of 7.9 mg DMAE/kg feed
was reported to lead to DMAE residues in liver (5.4 mg/kg fresh tissue) and kidney (4.2 mg/kg fresh
tissue), while in abdominal fat and breast muscle the DMAE found was below the LOD of 8.3 mg/kg
DM.27 Notwithstanding the uncertainties in the quantiﬁcation of DMAE residues, the FEEDAP
Panel considers that the deposition data can be used in the safety assessment of DMAE. In the study,
the concentration of DMAE was about eightfold the maximum expected level of 0.9 mg DMAE/kg feed,
when Taminizer D is used at the maximum dose proposed. The deposition rate of DMAE that would
result from feeding birds with the additive containing DMAE at the maximum measured concentration
in the additive was not investigated; however, it can reasonably be expected that feeding the additive
to the birds would result in lower levels of residues than those observed in the study with the
overdose evaluated. In addition, the FEEDAP Panel recognises that poultry offal is a food commodity of
25 Information sent by the applicant (e-mail received on 27.3.2018). The FEEDAP Panel notes that, according to the information
provided in the dossier, the analytical method was veriﬁed in another laboratory and the limits of detection and quantiﬁcation
reported were 2 and 1 mg/kg DM, respectively.
26 Being advertised for intake at doses of 300–2,000 mg DMAE/day.
27 Technical dossier/Section II/2.Annex II_6.
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minor importance in most food consumption scenarios throughout the EU. Using the ﬁgures of the
Food Basket described in Commission Regulation (EC) No 429/2008 for poultry offal consumption
(100 g/day and 10 g/day for liver and kidney, respectively), the deposition resulting from an eightfold
overdosing of DMAE in poultry feed would result in a daily intake of 0.59 mg/day (0.45 mg plus 0.042
mg from liver and kidney, respectively) or 0.007 mg/kg bw per day. Considering the uncertainties, the
DMAE content in muscle and fat plus skin is set at the LOD, resulting in 3.4 mg/kg fresh tissue.
Considering the food basket ﬁgures, this will lead to an additional intake of 1.33 mg/kg (1.02 mg plus
0.31 mg from meat and skin plus fat, respectively). The resulting consumer intake from tissues of
poultry fed Taminizer with a DMAE concentration at least eightfold higher than expected would be 1.92
mg/day, or 0.032 mg/kg bw day in a 60-kg individual. This highly conservative estimate is considered
to account for the uncertainty concerning the possible background content in foods.
The limited available toxicological data are inadequate to derive a safe level upon oral route;
however, they do not indicate that DMAE has a potential for genotoxicity.
The FEEDAP Panel applied the TTC approach, considering that this procedure can be applied to
impurities for which no health guidance value can be derived. DMAE is a compound of Cramer Class I
and the TTC is therefore 30 lg (or 0.030 mg)/kg bw per day (EFSA Scientiﬁc Committee, 2012); this
value corresponds to the estimated DMAE intake resulting from the use of Taminizer D with DMAE
level as high as eightfold that expected.
Therefore, the FEEDAP Panel considers that the evidence is sufﬁcient to conclude that the presence
of DMAE in feed of chickens for fattening as impurity of Taminizer D at levels up to 0.9 mg/kg feed is
unlikely to pose concerns for consumers’ safety.
3.2.3.1. Conclusions on safety for the consumer
The presence of DMAE in animal feed as an impurity of Taminizer D at levels up to 0.9 mg/kg feed
is unlikely to be of concern for consumer safety. Therefore, the FEEDAP Panel concludes that Taminizer
D, manufactured by the DMAE route, is safe for consumers when used in feed for chickens for
fattening up to the maximum level of 1,000 mg/kg feed, and with a maximum DMAE content in the
additive of 0.1%.
3.2.4. Safety for the user
In a subchronic inhalation study on rats of DMAE, lesions of the upper respiratory tract and corneal
opacity were observed, with a NOAEC of 87.5 mg/m3. A lower NOAEC (36.5 mg/m3) was observed for
maternal toxicity (reduced body weight gain and ocular changes) in a developmental toxicity study on
rat dams by inhalation.
The new manufacturing process has not increased the dusting potential or the fraction of inhalable
particles: particles below 50 lm are on average 0.68% and < 0.1% in Taminizer D produced with the
current method or with the new proposed method, respectively, and dusting potential classiﬁed as
nearly dust free (see also EFSA FEEDAP Panel, 2011a and Section 3.1.2. above); therefore, the
inhalation exposure to DMAE present as an impurity in Taminizer D is expected to be very low (lower
than the NOAECs reported in the toxicity studies). Consequently, the FEEDAP Panel considers that the
health risk to users by the inhalation route is also very low.
According to the information provided in the literature search, DMAE is not a skin sensitiser;
however, it can causes severe skin burns and serious eye damage. The FEEDAP Panel considers that
the damage to tissues upon direct contact with DMAE is a result of the corrosive nature of DMAE.
Conversely, low concentrations of DMAE are not expected to cause corrosion of tissues; the compound
is safely used in cosmetics28 in concentrations of about 3% (Grossman, 2005). It is noted that DMAE is
not genotoxic, and the concentrations of DMAE in Taminizer D (≤ 0.1%) are sufﬁciently low that skin
exposure to the product is unlikely to cause any local or systemic toxicity.
When assessed previously by the FEEDAP Panel, Taminizer D was considered as a skin sensitiser,
not irritant to skin, but possibly irritant to eyes. The DMAE impurities in Taminizer D produced by the
new method of manufacture, if present at concentrations ≤ 0.1% in the additive, is not expected to
increase or change the risk to users resulting from exposure of skin and eyes to the product during
normal handling in the workplace.
28 ‘2-Dimethylaminoethanol; N,N-Dimethyl-2-aminoethanol’ is listed as a cosmetic ingredient (dimethyl MEA) in the EU Cosmetic
ingredient database. Available online: https://ec.europa.eu/growth/sectors/cosmetics/cosing_en
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3.2.4.1. Conclusions on safety for the user
The FEEDAP Panel extends its conclusions about Taminizer D produced by the original method to
cover also Taminizer D produced by the new method (containing DMAE as impurity at concentrations
≤ 0.1% in the additive). There is minimal risk to users from dust produced as a result of normal
handling of the additive. Taminizer D is not irritant to skin but may be irritant to eyes. It is regarded as
a potential skin sensitiser.
3.2.5. Safety for the environment
In its previous assessment (EFSA FEEDAP Panel, 2011a), the FEEDAP Panel considered that the use
of the product as a feed additive for chickens for fattening would not pose a risk to the environment.
Taking into account the amount of DMAE potentially present in the additive, the FEEDAP
Panel considers that the conclusions on the safety for the environment do apply to the product
currently under assessment.
3.3. Efﬁcacy
In its previous assessment (EFSA FEEDAP Panel, 2011a), the FEEDAP Panel considered that the use
of the additive at the recommended dose has the potential to improve the performance of chickens for
fattening. The FEEDAP Panel considers that the presence of DMAE impurities (≤ 0.1%) does not affect
the previous conclusions on efﬁcacy.
3.4. Post-market monitoring
The FEEDAP Panel considers that there is no need for speciﬁc requirements for a post-market
monitoring plan other than those established in the Feed Hygiene Regulation29 and Good
Manufacturing Practice.
4. Conclusions
Since the safety of the active substance, DMG-Na, has been established, the current assessment
has dealt with the impurity DMAE, which is introduced in the additive at concentrations up to 0.09%
as a result of a modiﬁed manufacturing process.
Taking into account the toxicological proﬁle of DMAE, the estimated intake by the target animal and
making use of the TTC approach, the FEEDAP Panel concludes that the presence of DMAE in Taminizer
D up to the highest level detected in the additive is unlikely to cause adverse effects in chickens for
fattening. Therefore, Taminizer D, manufactured by the DMAE route, is safe for chickens for fattening
up to the maximum level of 1,000 mg/kg feed (DMAE content ≤ 0.1% in the additive).
The presence of DMAE in animal feed as an impurity of Taminizer D at levels up to 0.9 mg/kg feed
is unlikely to be of concern for consumer safety. Therefore, the FEEDAP Panel concludes that Taminizer
D, manufactured by the DMAE route, is safe for consumers when used in feed for chickens for
fattening up to the maximum level of 1,000 mg/kg feed (DMAE content ≤ 0.1% in the additive).
As regards user safety, the FEEDAP Panel extends its conclusions about Taminizer D produced by
the original method to cover also Taminizer D produced by the new method (containing DMAE as
impurity at concentrations ≤ 0.1% in the additive). There is minimal risk to users from dust produced
as a result of normal handling of the additive. Taminizer D is not irritant to skin but may be irritant to
eyes. It is regarded as a potential skin sensitiser.
The FEEDAP Panel considers that the conclusions of the previous assessment of Taminizer D on the
safety for the environment do apply to the product currently under assessment, and thus, the additive
would not pose a risk to the environment.
In its previous assessment of Taminizer D, the FEEDAP Panel considered that the use of the
additive at the recommended dose has the potential to improve the performance of chickens for
fattening. The FEEDAP Panel considers that the presence of DMAE impurities (≤ 0.1%) does not affect
the previous conclusions on efﬁcacy.
29 Regulation (EC) No 183/2005 of the European Parliament and of the Council of 12 January 2005 laying down requirements for
feed hygiene. OJ L 35, 8.2.2005, p. 1.
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5. Recommendations
The FEEDAP Panel recommends that a speciﬁcation for DMAE content in the additive should be set.
A level of ≤ 0.1% is proposed on the basis of data on characterisation of the additive and on safety
aspects of the impurity.
Documentation provided to EFSA
1) Taminizer D (dimethylglycine sodium salt) for chickens for fattening. December 2016.
Submitted by Taminco BVBA, a subsidiary of Eastman Chemical Company.
2) Taminizer D (dimethylglycine sodium salt) for chickens for fattening. Supplementary information.
October 2017. Submitted by Taminco BVBA, a subsidiary of Eastman Chemical Company.
3) Taminizer D (dimethylglycine sodium salt) for chickens for fattening. Supplementary
information (provided by e-mail). January 2018. Submitted by Taminco BVBA, a subsidiary of
Eastman Chemical Company.
4) Comments from Member States.
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Abbreviations
ALP alkaline phosphatase
AST aspartate aminotransferase
bw body weight
CHO Chinese hamster ovary
CIPAC Collaborative International Pesticides Analytical Council
DM dry matter
Taminizer D (dimethylglycine sodium salt) as a feed additive for chickens for fattening
www.efsa.europa.eu/efsajournal 11 EFSA Journal 2018;16(5):5268
DMAE dimethylamino-ethanol
DMG-Na dimethylglycine sodium salt
EURL European Union Reference Laboratory
FEEDAP EFSA Panel on Additives and Products or Substances used in Animal Feed
GGT gamma-glutamyl transferase
HGPRT hypoxanthine-guanine-phosphoribosyltransferase
LOD limit of detection
LOQ limit of quantiﬁcation
NIEHS US National Institute of Environmental Health Sciences
NOAEC no-observed adverse-effect concentration
NOAEL no-observed-adverse-effect level
NOEL no-observed-effect level
PCB polychlorinated biphenyl
PCDD/-F polychlorinated dibenzo-p-dioxin/dibenzofuran
TEQ toxic equivalent
TTC Threshold of Toxicological Concern
WHO World Health Organization
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